Tag: Abbott Laboratories

April 15, 2019 Off

Colorectal Cancer Therapeutics: Global Markets to 2023 with Abbott Laboratories, Bayer Healthcare, GlaxoSmithKline, Merck & Co, Pfizer and Sanofi at the Forefront

Global Markets to 2023 with Abbott Laboratories, Bayer Healthcare, GlaxoSmithKline, Merck & Co, Pfizer and Sanofi at the Forefront

February 8, 2017 Off

Allergy Therapeutics appoints Abbott’s Licensing and Acquisitions Vice President to its Board

By Dino Mustafić

Allergy Therapeutics has appointed Jeff Barton to the Company’s Board as a Non-Executive Director, nominated by Abbott Laboratories in replacement of Mr Jean-Yves Pavee who retires from the Board, both effective after close of business 7 February 2017.